Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Foundation for Autoimmune and Autoinflammatory Arthritis (AiArthritis) is a global, patient-led non-profit organization dedicated to improving the lives of individuals affected by autoimmune and autoinflammatory diseases where arthritis is a major clinical component. The foundation focuses on three primary pillars: education, advocacy, and research, aiming to bridge the gap between patients and the scientific community. By facilitating collaborative projects, AiArthritis ensures the patient voice is central to drug development, clinical trial design, and healthcare policy. Their initiatives target a broad spectrum of conditions, including Rheumatoid Arthritis, Psoriatic Arthritis, and various rare autoinflammatory disorders. Ultimately, the organization works to accelerate early detection and improve access to personalized treatments for patients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Foundation for Autoimmune and Autoinflammatory Arthritis.